2 documents found, page 1 of 1
Cost-effectiveness of Xpert®MTB/RIF in the diagnosis of tuberculosis: pragmatic...
Silva,Suely Conceição Alves da; Vater,Maria Claudia; Ramalho,Daniela Maria de Paula; Almeida,Isabela Neves de; Miranda,Silvana Spíndola deAbstract INTRODUCTION: The intensification of research and innovation with the creation of networks of rapid and effective molecular tests as strategies for the end of tuberculosis are essential to avoid late diagnosis and for the eradication of the disease. We aimed to evaluate the cost-effectiveness of Xpert®MTB/RIF (Xpert) in the diagnosis of drug-resistant tuberculosis in reference units, in scenarios with ...
Clinical impact and cost analysis of the use of either the Xpert MTB Rif test o...
Castro,Anália Zuleika de; Moreira,Adriana Rezende; Oliveira,Jaqueline; Costa,Paulo Albuquerque; Graça,Carolyne Lalucha Alves Lima DaAbstract INTRODUCTION: The molecular test Xpert MTB/RIF (Xpert) has been recommended for use in the diagnosis of pulmonary tuberculosis (PTB); however, data on the cost of incorporating it under routine conditions in high-burden countries are scarce. The clinical impact and costs incurred in adopting the Xpert test in routine PTB diagnosis was evaluated in a prospective study conducted from November 2012 to Nov...